These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1721824)

  • 1. Cyclosporine, FK-506 and other drugs in organ transplantation.
    Morris PJ
    Curr Opin Immunol; 1991 Oct; 3(5):748-51. PubMed ID: 1721824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive agents: recent developments in molecular action and clinical application.
    Gerber DA; Bonham CA; Thomson AW
    Transplant Proc; 1998 Jun; 30(4):1573-9. PubMed ID: 9636637
    [No Abstract]   [Full Text] [Related]  

  • 3. New small molecule immunosuppressants for transplantation: review of essential concepts.
    Morris RE
    J Heart Lung Transplant; 1993; 12(6 Pt 2):S275-86. PubMed ID: 7508752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New immunosuppressive drugs in transplantation].
    Surdacka E; Sułowicz W; Surdacki A
    Przegl Lek; 1994; 51(8):347-54. PubMed ID: 7532870
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin.
    Zeevi A; Woan M; Yao GZ; Venkataramanan R; Todo S; Starzl TE; Duquesnoy RJ
    Transplant Proc; 1991 Dec; 23(6):2928-30. PubMed ID: 1721315
    [No Abstract]   [Full Text] [Related]  

  • 6. New immunosuppressive drugs in transplantation.
    Groth CG; Ohlman S; Gannedahl G; Ericzon BG
    Transplant Proc; 1993 Aug; 25(4):2681-3. PubMed ID: 7689274
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular mechanisms of new immunosuppressants.
    Halloran PF
    Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo.
    Gregory CR; Pratt RE; Huie P; Shorthouse R; Dzau VJ; Billingham ME; Morris RE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):770-1. PubMed ID: 7679842
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppressive regimens of tomorrow.
    Groth CG
    Transplant Proc; 1995 Dec; 27(6):2971-3. PubMed ID: 8539797
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of various immunosuppressive drugs in preventing pig-to-rat islet xenograft rejection.
    Wennberg L; Wallgren AC; Karlsson-Parra A; Kozlowski T; Sundberg B; Tibell A; Groth CG; Korsgren O
    Transplant Proc; 1995 Feb; 27(1):266-7. PubMed ID: 7533391
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo immunopharmacology of the macrolides FK 506 and rapamycin: toward the era of rational immunosuppressive drug discovery, development, and use.
    Morris RE
    Transplant Proc; 1991 Dec; 23(6):2722-4. PubMed ID: 1721257
    [No Abstract]   [Full Text] [Related]  

  • 12. Advances in immunosuppression for heart transplantation.
    Kobashigawa JA
    Adv Card Surg; 1998; 10():155-74. PubMed ID: 9917904
    [No Abstract]   [Full Text] [Related]  

  • 13. New horizons in immunosuppression.
    Simmons RL; Wang SC
    Transplant Proc; 1991 Aug; 23(4):2152-6. PubMed ID: 1714645
    [No Abstract]   [Full Text] [Related]  

  • 14. Probing T-cell signal transduction pathways with the immunosuppressive drugs, FK-506 and rapamycin.
    Siekierka JJ
    Immunol Res; 1994; 13(2-3):110-6. PubMed ID: 7539823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The actions of cyclosporin A and FK506 on T-lymphocyte activation.
    Mattila PS
    Biochem Soc Trans; 1996 Feb; 24(1):45-9. PubMed ID: 8674715
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunopharmacology of new xenobiotic immunosuppressive molecules.
    Morris RE
    Semin Nephrol; 1992 Jul; 12(4):304-14. PubMed ID: 1384096
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: implications for clinical composite tissue transplantation.
    Jones NF; Hebebrand D; Buttemeyer R; Zhao M; Benhaim P; Rao U
    Plast Reconstr Surg; 2001 Mar; 107(3):777-84. PubMed ID: 11304605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modes of action of FK506, cyclosporin A, and rapamycin.
    Morris R
    Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
    [No Abstract]   [Full Text] [Related]  

  • 19. New immunosuppressive agents for organ transplantation.
    Waer M
    Acta Clin Belg; 1997; 52(4):199-203. PubMed ID: 9351290
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin.
    Bierer BE
    Proc Assoc Am Physicians; 1995 Apr; 107(1):28-40. PubMed ID: 8630742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.